Olteanu H - Search Results

1

Utility of flow cytometry screening before MRD testing in multiple myeloma.

Panakkal V, Lakshman A, Shi M, Olteanu H, Horna P, Timm MM, Otteson GE, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Rajkumar SV, Kumar SK, Jevremovic D. Panakkal V, et al. Among authors: olteanu h. Blood Cancer J. 2023 Apr 20;13(1):55. doi: 10.1038/s41408-023-00832-8. Blood Cancer J. 2023. PMID: 37080968 Free PMC article. No abstract available.

2

Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.

Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH. Olteanu H, et al. Leuk Lymphoma. 2010 Mar;51(3):481-7. doi: 10.3109/10428190903552120. Epub 2010 Feb 8. Leuk Lymphoma. 2010. PMID: 20141431

3

CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.

Plaza JA, Ortega P, Lynott J, Mullane M, Kroft S, Olteanu H. Plaza JA, et al. Among authors: olteanu h. Am J Dermatopathol. 2010 Jul;32(5):489-91. doi: 10.1097/DAD.0b013e3181c57ec2. Am J Dermatopathol. 2010. PMID: 20442639 Review.

4

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. Kanate AS, et al. Among authors: olteanu h. Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2. Br J Haematol. 2018. PMID: 28771676 Free PMC article. No abstract available.

5

Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.

Hari P, Raj RV, Olteanu H. Hari P, et al. Among authors: olteanu h. N Engl J Med. 2016 Oct 13;375(15):1501-1502. doi: 10.1056/NEJMc1605684. N Engl J Med. 2016. PMID: 27732828 No abstract available.

6

Immunophenotypic studies of monoclonal gammopathy of undetermined significance.

Olteanu H, Wang HY, Chen W, McKenna RW, Karandikar NJ. Olteanu H, et al. BMC Clin Pathol. 2008 Nov 28;8:13. doi: 10.1186/1472-6890-8-13. BMC Clin Pathol. 2008. PMID: 19040735 Free PMC article.

7

High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency.

Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH. Olteanu H, et al. Bone Marrow Transplant. 2012 Mar;47(3):399-403. doi: 10.1038/bmt.2011.83. Epub 2011 Apr 11. Bone Marrow Transplant. 2012. PMID: 21478917

8

Circulating Breast Carcinoma Cells Mimicking Therapy-Related Acute Myeloid Leukemia.

Rowan DJ, Logunova V, van Tuinen P, Olteanu H, Peterson JF. Rowan DJ, et al. Among authors: olteanu h. Int J Surg Pathol. 2017 Feb;25(1):87-93. doi: 10.1177/1066896916664986. Epub 2016 Aug 20. Int J Surg Pathol. 2017. PMID: 27543510

9

Acute hemolytic transfusion reaction secondary to anti-Fy3.

Olteanu H, Gerber D, Partridge K, Sarode R. Olteanu H, et al. Immunohematology. 2005;21(2):48-52. Immunohematology. 2005. PMID: 15981343

10

The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.

Harrington A, Olteanu H, Kroft S. Harrington A, et al. Among authors: olteanu h. Am J Clin Pathol. 2010 Nov;134(5):749-61. doi: 10.1309/AJCPFNF5MN1GDWKU. Am J Clin Pathol. 2010. PMID: 20959658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page